共 90 条
[1]
Villanueva A(2019)Hepatocellular carcinoma N Engl J Med. 380 1450-1462
[2]
Hsin IF(2011)Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction J Clin Gastroenterol. 45 556-562
[3]
Hsu CY(2020)A changing paradigm for the treatment of intermediate-stage hepatocellular carcinoma: Asia-Pacific primary liver cancer expert consensus statements Liver Cancer. 9 245-260
[4]
Huang HC(2015)Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade J Clin Oncol. 33 550-558
[5]
Huang YH(2019)Validation of modified ALBI grade for more detailed assessment of hepatic function in hepatocellular carcinoma patients: a multicenter analysis Liver Cancer. 8 121-129
[6]
Lin HC(2019)Tumor size affects efficacy of adjuvant transarterial chemoembolization in patients with hepatocellular carcinoma and microvascular invasion Oncologist. 24 513-520
[7]
Lee RC(2018)Up-to-seven criteria as a useful predictor for tumor downstaging to within Milan criteria and Child-Pugh grade deterioration after initial conventional transarterial chemoembolization Hepatol Res. 48 442-450
[8]
Kudo M(2017)New intermediate-stage subclassification for patients with hepatocellular carcinoma treated with transarterial chemoembolization Liver Int. 37 1861-1868
[9]
Han KH(2020)Changes in background liver function in patients with hepatocellular carcinoma over 30 years: comparison of child-pugh classification and albumin Bilirubin grade Liver Cancer. 9 518-528
[10]
Ye SL(2018)Validation of the albumin-bilirubin grade-based integrated model as a predictor for sorafenib-failed hepatocellular carcinoma Liver Int. 38 321-330